earnings
saveGSK plc earnings
community read0 votes
Anticipated earnings call for GSK plc ($GSK).
view source ↗Data sources
Found something off?
same company · ±60 days · 6
- patent expiry(abacavir sulfate + dolutegravir sodium + lamivudine): GSK plc — (abacavir sulfate + dolutegravir sodium+ lamivudine) ODT (Constraining Patent Expiry (Japan))Apr 28, 2026
- patent expirycabotegravir sodium: GSK plc — cabotegravir sodium (Constraining Patent Expiry (US))Apr 28, 2026
- drug expirycabotegravir sodium: GSK plc — cabotegravir sodium (Drug Expiry (US))Apr 28, 2026
- phase 1 completionbepirovirsen sodium: GSK plc — bepirovirsen sodium (Phase I Trial Completion)Apr 28, 2026
- patent expirydolutegravir sodium: GSK plc — dolutegravir sodium ODT (Constraining Patent Expiry (Japan))Apr 28, 2026
- phase 2 initiationdostarlimab: GSK plc — dostarlimab (Phase II Trial Initiation)Apr 25, 2026
🐶 often sniffed alongside
top 8- company$GLAXFGSK plc6 co-mentions · 6 sources
- tagInfectious Disease6 co-mentions · 6 sources
- drugdolutegravir sodium2 co-mentions · 2 sources
- drugcabotegravir LA2 co-mentions · 2 sources
- drugcabotegravir sodium2 co-mentions · 2 sources
- drugdolutegravir sodium ODT2 co-mentions · 2 sources
- drugdostarlimab1 co-mentions · 1 sources
- drugbepirovirsen sodium1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that